An Assessment of Cancer Education Needs to Promote Mid-Adult HPV Vaccination Among Male Sexual Minorities.

An Assessment of Cancer Education Needs to Promote Mid-Adult HPV Vaccination Among Male Sexual Minorities.
复制标题

癌症教育评估需要促进男性性少数人群中成人 HPV 疫苗接种。

DOI:
10.1007/s13187-019-01644-w
复制
发表时间:
2021
期刊:
Journal of cancer education : the official journal of the American Association for Cancer Education
影响因子:
--
通讯作者:
Maness,SarahB
Maness,SarahB
中科院分区:
--
文献类型:
--
作者:
Wheldon,ChristopherW;Maness,SarahB

文献摘要

相似文献

本研究的目的是评估男性性少数群体 (MSM) 中关于年龄扩大的人乳头瘤病毒 (HPV) 疫苗接种计划的行为期望和相关心理社会因素。对行为期望 (BE) 的衡量标准(“如果 CDC 建议更改为包括 26 岁以上的男性,您接种 HPV 疫苗的可能性有多大?”)在 MSM 的不同种族样本 (N= 318) 上进行了评估。如果建议改变,百分之六十七的人可能会开始接种疫苗。 HPV 疫苗接种的好处得到了广泛认可。疫苗接种的障碍/危害得到认可的频率较低。只有 15.4% 的人担心疫苗无效。 BE 的主要驱动因素是感知到的身体益处(R2= 0.34)。心理益处与 BE 独立相关,但并未改善解释模型。在扩大的年龄范围内,MSM 对 HPV 疫苗接种的期望很高。预防肛门生殖器疣和肛门癌是该人群的一个重要考虑因素;然而,宣传疫苗接种的益处必须根据对老年性活跃男男性接触者疫苗功效的现实预期来进行。
The purpose of this study was to assess behavioral expectations and related psychosocial factors regarding an age-expanded human papillomavirus (HPV) vaccine schedule among male sexual minorities (MSM). A measure of behavioral expectation (BE) (“How likely are you to get the HPV vaccine if the CDC recommendation was changed to include men older than 26?”) was evaluated on an ethnoracially diverse sample (N= 318) of MSM. Sixty-seven percent wouldlikelyinitiate vaccination if the recommendations change. Benefits of HPV vaccination were widely endorsed. Barriers/harms of vaccination were endorsed less frequently. Only 15.4% were concerned that the vaccine would not be effective. The main driver of BE was perceived physical benefits (R2= 0.34). Psychological benefits were independently associated with BE but did not improve the explanatory model. Expectation of HPV vaccination is high among MSM in the expanded age range. Prevention of anogenital warts and anal cancer is an important consideration for this population; however, promoting the benefits of vaccination must be done in accordance with realistic expectations of vaccine efficacy in older sexually active MSM.